Skip to content
NOWCAST WISN 12 News This Morning
Watch on Demand
Advertisement

COVID-19 vaccine effectiveness for immunocompromised

UW doctors are studying how well the shots work

COVID-19 vaccine effectiveness for immunocompromised

UW doctors are studying how well the shots work

NOW. RESEARCHERS AT UW MADISON ARE STUDYING THE EFFECTIVENESS OF THE NEW COVID VACCINES IN PEOPLE WHO ARE IMMUNOCOMPROMISED. JOINING US HERE AT FOREST, DR. FREDDY CALDEIRA, A GASTROENTEROLOGIST AT UW HEALTH. WHAT WHAT IS THIS NEW STUDY. WELL, FIRST OF ALL, THANK YOU FOR HAVING ME. SO TAKE CARE OF PATIENTS WITH CROHN’S AND ULCERATIVE COLITIS. COMPROMISE ABOUT 4 MILLION AMERICANS AND THEY’RE COMMONLY TREATED WITH EITHER SUPPRESSIVE THERAPY. SO WE ARE DOING A FOLLOW UP STUDY TO OUR ORIGINAL STUDY TO MAKE SURE PATIENTS ARE PROTECTED FOR SIX MONTH PERIOD, WHICH IS THE TIME WHEN WE’RE REALLY DEALING WITH COVID. WHAT HAVE WE SEEN FROM IMMUNOCOMPROMISED PEOPLE GETTING COVID VACCINES IN RECENT YEARS? SO WE DID AN ORIGINAL STUDY ALONG WITH SOME OTHERS, AND WE FOUND THAT AT LEAST THE PATIENTS WE TREAT WITH THE MEDICINES ARE ABLE TO MOUNT A VACCINE RESPONSE. INITIALLY. WE OUR HOPE WITH A FOLLOW UP STUDY, WHICH WE’RE DOING A MULTICENTER STUDY, IS TO MAKE SURE THAT THE PROTECTION LASTS FOR THE WHOLE RESPIRATORY SEASON. AND WHAT’S THE HOPE FOR THIS NEW STUDY AND WHEN DO YOU THINK YOU’LL HAVE YOUR RESULTS THAT YOU’RE LOOKING FOR. SO THE HOPE IS THAT IT? YOU KNOW, THERE ARE A LOT OF DIFFERENT GROUPS THAT ARE IMMUNOCOMPROMISED AND AND THE THERAPIES THEY TAKE EITHER HELP FEELING THEM BETTER, WHETHER THEY HAVE RHEUMATOID ARTHRITIS, CROHN’S DISEASE. WE WANT TO MAKE SURE THAT PATIENTS DON’T FEEL THAT THEY’RE TAKING A MEDICINE THAT HELPS THEM, BUT THERE COMES WITH A RISK. SO WE EXPECT TO HAVE SOME RESULTS BY NEXT SUMMER SHOWING THAT I FEEL WE’RE GOING TO FIND THAT THE VACCINE WORK WELL AND THEY PROVIDE PROTECTION FOR THE WHOLE TIME. FOR SOMEONE WHO IS WATCHING AND THEY’RE INTERESTED, HOW CAN THEY GET INVOLVED. WE HAVE A PRESS RELEASE. WE’RE STILL RECRUITING PATIENTS AND OUR GOAL IS TO ULTIMATELY SHARE THIS AS WE SHARE THE ORIGINAL STUDIES. SO IT PROVIDES REASSURANCE TO PATIENTS THAT THE THERAPY THEY TAKE, WHILE IT MAKES THEM FEEL BETTER, IT’S NOT PUTTING THEM AT INCREASED RISK FOR INFECTIONS. ALL RIGHT, DOCTOR, THANK YOU SO MUCH FOR YOUR TIME FOR JOINING US HERE
Advertisement
COVID-19 vaccine effectiveness for immunocompromised

UW doctors are studying how well the shots work

UW doctors are studying how well the shots work.

UW doctors are studying how well the shots work.

Advertisement